| Application no. and date | 11833072.9 (espacenet) (Federated) (European Patent Register), 20110928 | | Patent/reg. no. and date | DK/EP 2621945, 20180411 | | Publication date | 20130807 | | Priority no. and date | US 387439 P, 20100928 | | EP pub. no. and date |
EP 2621945 20130807 | | Effective date | | | Applicant/owner | NoNO Inc., 88 Strath Avenue
Toronto ON M8X 1R5, CA | | Applicant ref. no. | V1804-030-DK | | Inventor | TYMIANSKI, Michael, 175 Dawlish Avenue
Toronto
Ontario M4N 1H6, CA,
LI, Rongwen, 904 Kennedy Road
Toronto
Ontario M1K 2E8, CA,
GARMAN, Jonathan David, 148 Lawrie Road
Thornhill
Ontario L4J 8N1, CA | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 25/00 (2006.01) , A61P 35/00 (2006.01) , C07K 14/47 (2006.01) , C07K 19/00 (2006.01) | | Title | ND2-PEPTIDER OG FREMGANGSMÅDER TIL BEHANDLING AF NEUROLOGISK SYGDOM | | Int. application no. | US2011053764 | | Int. publication no. | WO2012050921 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
